Oncodesign Company

Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Technology: Precision Medicine
Industry: P4 Medicine
Headquarters: Others
Founded Date: 1995-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 3
Total Funding: $29.4M
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
contact@oncodesign.com
https://www.twitter.com/oncodesignsa
Register and Claim Ownership